No new news, page-2

First 2 Last

Share
Profile

Follow
Whynot50

1,041 Posts.

14

01/11/17

13:48

Post #: 28396677
Share

Originally posted by Farnarkling ↑

Well I must say the trading update from Broo was pretty disappointing. Nothing new, other than they now own and operate a restaurant/brewery in Mildura. Good luck with that!

On that topic, the alarm bells should be ringing - why would you talk about all this product demand, and in the same update, tell us that increased capacity will allow Broo to contract-brew for others. A quick reality check here: Mildura were already brewing for others before Broo came along. So nothing new, in fact, disappointedly so.

The ALM deal is just a re-hash of previous news - Broo....we already knew about it. Moving swiftly on.

The Sorrento Brewery did not get much air-time, which is odd given they're planning to open next month. One can only assume there's no real brewery, just a bar which is branded as a brewery.

And interestingly, nothing on the fantasy brew-land in Ballarat. I guess we'll forget about that one and allow the option on the land to lapse.

Finally, it's most often interesting to think about what was not said. They now have $2.5m in new debt since we last heard from them, and you can bet your bottom dollar the debt-holder(s) rank well ahead of the ordinary shareholders.

Is it time to man the life-boats? Hmmmm...think I'll just don the life-jacket just in case.

Continuing to watch with interest.

Expand

We're having an above average volume day so there are a few investors that see Broo's potential. I hope their next announcement will be a rocket that'll blow your socks off. That'd be farnarkling great

BEE Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome